Home

arrow iconNewsarrow iconarrow icon

CDSCO IVF Reagent Sale Norms Tightened: Manufacturers and Distributors Told to Supply Only to Registered ART Clinics

CDSCO IVF Reagent Sale Norms Tightened: Manufacturers and Distributors Told to Supply Only to Registered ART Clinics

India's Central Drugs Standard Control Organisation has overhauled CDSCO IVF reagent sale norms, directing that all ART media, culture solutions, and reagents be supplied exclusively to clinics registered under the ART (Regulation) Act and Surrogacy (Regulation) Act. The move targets a growing unlicensed supply chain feeding an estimated 40–50% of India's 2,000-plus IVF centres.

By FertilityIn

02 Jul 2026

1 min read

CDSCO IVF Reagent Sale Norms Tightened: Manufacturers and Distributors Told to Supply Only to Registered ART Clinics

India's drug regulatory authority has reinforced compliance requirements for the sale and distribution of assisted reproductive technology (ART) products, directing stakeholders to supply IVF media, reagents, and related products only to centres registered under the country's ART and surrogacy laws. The move strengthens CDSCO IVF Reagent Sale Norms aimed at ensuring patient safety and preventing the misuse of reproductive technologies.


In a recent regulatory communication, the Central Drugs Standard Control Organisation (CDSCO) stated that all medical devices, including media, reagents, and other products used in assisted reproductive procedures such as in-vitro fertilisation (IVF) and cryopreservation, are regulated under the Medical Devices Rules, 2017. Manufacturers and importers of these products are required to obtain the necessary licences to ensure the quality, safety, and performance of the devices.


According to the regulator, these products are intended for use by ART clinics and banks that are registered under the Assisted Reproductive Technology (Regulation) Act, 2021, and the Surrogacy (Regulation) Act, 2021. These laws were introduced to promote the safe, ethical, and regulated delivery of reproductive healthcare services across India.


The regulator noted that it has come to its attention that IVF media and related products are being supplied to facilities that are not registered under the applicable legislation. Such practices, CDSCO warned, could increase the risk of misuse of assisted reproductive technologies and potentially compromise patient health and welfare.


To address these concerns, the authority has urged manufacturers, importers, distributors, and other stakeholders to ensure that the supply of ART media and reagents is limited exclusively to centres registered under the ART and Surrogacy Acts. The updated CDSCO IVF Reagent Sale Norms are intended to strengthen regulatory oversight while supporting ethical reproductive healthcare practices nationwide.


The latest directive further aligns the regulation of reproductive technology products with India's broader medical device framework, reinforcing traceability and accountability throughout the supply chain. By tightening CDSCO IVF Reagent Sale Norms, the regulator aims to ensure that sensitive reproductive products remain accessible only to authorised facilities operating within the country's legal and ethical framework.

24 views

Share

FertilityIn

Send Enquiry for this Story

Related Articles

Canadian Survey Shows 49% Support Federal IVF Funding, While 60% Are Unaware of Treatment Costs

Canadian Survey Shows 49% Support Federal IVF Funding, While 60% Are Unaware of Treatment Costs

A new Ipsos survey commissioned by Fertility Matters Canada finds 49% of Canadians with an opinion support a national baseline for IVF funding support, with backing rising to 59% among those aged 18–34. One in eight Canadians say cost has already forced them or someone close to delay or abandon fertility treatment.

IVF

1 min read

Alpha Controls Named Third-Party Calibration Partner for FertiTech Canada’s Nilotech Temperature Probes

Alpha Controls Named Third-Party Calibration Partner for FertiTech Canada’s Nilotech Temperature Probes

Alpha Controls & Instrumentation Inc. has been selected by FertiTech Canada Inc. as its third-party calibration partner for Nilotech temperature probes. The partnership channels Canadian IVF laboratories and fertility clinics using Nilotech equipment to Alpha Controls for professional, accredited calibration services, while FertiTech continues to handle equipment supply and gas sensor calibration.

IVF

1 min read

MP Seeks Legal Right to Paid Time Off for Fertility Treatment in Commons Bill

MP Seeks Legal Right to Paid Time Off for Fertility Treatment in Commons Bill

In the UK, a Ten Minute Rule Bill has been introduced in the Commons to create a legal right to paid time off for fertility treatment, aiming to standardize access to time‑sensitive appointments and reduce reliance on employer discretion. The proposal seeks House permission to proceed and spotlights workplace rights during Fertility Awareness Week.

IVF

1 min read

Columbia Researchers Report First Pregnancy Using AI-Guided Sperm Recovery Method​

Columbia Researchers Report First Pregnancy Using AI-Guided Sperm Recovery Method​

Columbia University Fertility Center has achieved the first confirmed pregnancy using an AI-guided sperm recovery method in a man with azoospermia, as detailed in The Lancet. The STAR system combined advanced imaging, microfluidics, and robotics to retrieve two viable sperm, enabling embryo creation after prior failed surgical and manual attempts.

IVF

1 min read

B.C. Free IVF Program Funding Depleted, Leaving Patients on Long Waitlist

B.C. Free IVF Program Funding Depleted, Leaving Patients on Long Waitlist

British Columbia's free IVF program exhausts 2025 funding within months of launch. At least one approved clinic stops accepting new applications. Applicants face aging-out risks and must wait until spring 2026 for next funding allocation.

IVF

1 min read

MOH Expands Genetic Conditions Approved for IVF Embryo Testing to 169, Enabling Couples to Reduce Inherited Disease Risks with Govt. Support

MOH Expands Genetic Conditions Approved for IVF Embryo Testing to 169, Enabling Couples to Reduce Inherited Disease Risks with Govt. Support

Singapore’s MOH approves 13 additional genetic conditions for testing before embryos are implanted during IVF, enhancing reproductive genetic screening options.

IVF

1 min read

NHS-Funded IVF in England: Regional Inequalities and Policy Variations Across ICBs

NHS-Funded IVF in England: Regional Inequalities and Policy Variations Across ICBs

National Health Service-funded IVF in England varies across regions in terms of access, cycle definitions, and eligibility. While Integrated Care Boards follow NICE guidelines, local implementation differs to meet specific population needs. Current policy reviews aim to enhance consistency and ensure continued access to fertility services across England.

IVF

1 min read

Landing Page Image

Subscribe to our Newsletter

Stay updated with the latest news, expert insights, and exclusive offers delivered straight to your inbox. Join our community today!

Email Address